Author: Rocca P. Sandei L. M. Bava I. Frieri T.
Publisher: Bentham Science Publishers
ISSN: 2211-5579
Source: Current Psychopharmacology, Vol.2, Iss.1, 2013-02, pp. : 29-36
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Long-Acting Injectable Risperidone for the Treatment of Schizophrenia: Clinical Perspectives
Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. :
Olanzapine Long-Acting Injection: A Review of its Use in the Treatment of Schizophrenia
Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. :
Long-acting risperidone adds value in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 443, 2003-01 ,pp. :